Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
04/2004
04/14/2004CN1489458A Inhibitors against the production and releaseof inflammator cytokines
04/13/2004US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal
04/13/2004US6720335 Sulfonamide inhibitors of aspartyl protease
04/08/2004WO2004029033A1 Valerolactone compounds and perfume composition
04/08/2004WO2004010761A3 Pesticidal cyanine dye derivatives
04/08/2004WO2004009564A3 Co-surfactants based on aldehydes
04/08/2004WO2003084919A3 Method for preparing combretastatins
04/08/2004WO2003018553A8 Oral antidiabetic agents
04/08/2004US20040068016 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
04/08/2004US20040067991 Tetrahydrobenzothiazole analogues as neuroprotective agents
04/08/2004US20040067931 Benzimidazolidinone derivatives as muscarinic agents
04/08/2004US20040067870 Fragrance raw materials aldehydes and pro-fragrances having a tertiary alpha carbon atom
04/08/2004DE19807502B4 Verfahren zur Nachvernetzung von Hydrogelen mit 2-Oxazolidinonen, daraus hergestellte Hydrogele und deren Verwendung Method for post-crosslinking of hydrogels with 2-oxazolidinones prepared therefrom hydrogels and their use
04/07/2004EP1405893A1 Organic electroluminescence device and luminance material
04/07/2004EP1404665A1 Antimicrobial and radioprotective compounds
04/07/2004EP1404664A1 Aminediols for the treatment of alzheimer's disease
04/07/2004EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents
04/07/2004EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
04/07/2004CN1487929A Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
04/07/2004CN1487919A New mandelic acid derivatives and their use as throbin inhibitors
04/07/2004CN1144789C Pyrrolidine and piperidine derivatives, producing process and application thereof
04/06/2004US6716980 Cyclization and acylation of carbamate
04/06/2004US6716865 Benzoxa- and benzthiazoles
04/06/2004US6716863 Heterocyclic compounds their production and use
04/06/2004US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent
04/06/2004US6716842 Non-insulin dependent diabetes mellitus, obesity, hyperglycemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia in a mammal
04/06/2004CA2067381C Treatment of hiv infections and compounds useful therein
04/01/2004WO2004026860A1 Methods of crystal precipitation
04/01/2004WO2004026849A1 Process for preparing substituted phenoxy-acetic acids from phenols
04/01/2004WO2004026848A1 Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
04/01/2004WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
04/01/2004US20040063965 Process for preparing oxazole intermediates
04/01/2004US20040063963 Dimerization; oxidation coupling of naphthol in presence of complex catalyst of copper chloride-tetramethylethylenediamine
04/01/2004US20040063790 By administering an organic peptidomimetic vibronectin receptor alpha v beta 3 antagonist of given structures
04/01/2004US20040063775 Five-membered heterocyclic alkanoic acid derivative
04/01/2004US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors
04/01/2004US20040063767 Reacting an alpha-substituted ketone with a cyclictetramine to form quaternaryammonium salt, reacting the salt with an acid to form alpha-amino ketone, reacting ketone with alpha-substitued acyl derivative in presence of a base
04/01/2004US20040063762 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
04/01/2004US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases
04/01/2004US20040063584 Benzazolonylcarbonylcyclohexenones and their use ss herbicides
04/01/2004US20040062713 Dye; photosensitive stimulant; using eye
04/01/2004CA2496726A1 Methods of crystal precipitation
03/2004
03/31/2004EP1403257A1 Processes for producing oxazolidinone derivative of beta-hydroxyethylamine compound and for producing beta-hydroxyethylamine compound
03/31/2004EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar)
03/31/2004EP1210324B1 Substituted cyclopentenes, their preparation and their use for chiral scaffolds
03/31/2004EP1095040B1 New benzoxazoles with pde-inhibiting activity
03/30/2004US6713651 β2-adrenergic receptor agonists
03/30/2004US6713630 Cyclization and acidification of 4-methyl-5-n-butoxyoxazole within tubular reactor
03/30/2004US6713059 Antibodies raised against immunogenic conjugates of gram-negative bacterial autoinducer molecules
03/30/2004CA2305933C (poly)thia-alcynoic compounds and their derivatives, compositions containing them and their uses
03/25/2004WO2004024705A1 Five-membered heterocyclic compounds
03/25/2004WO2004024675A1 Substituted aminoethers for the treatment of alzheimer's disease
03/25/2004WO2004024061A2 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers
03/25/2004WO2004000214A3 Use of compounds having an amine nucleus in manufacture of a medicament useful for treating factor viia-associated conditions
03/25/2004WO2003090680A3 Novel phenyl derivatives as inducers of apoptosis
03/25/2004WO2003086287A3 Compounds and methods for inducing apoptosis in proliferating cells
03/25/2004WO2003069350A3 Small molecule modulators of apoptosis
03/25/2004WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists
03/25/2004US20040059121 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin
03/25/2004US20040059120 Such as (5R)-3-(3-fluoro-4-(2-oxo-1,3-oxazolan-3-yl)phenyl)-5-hydroxymethyl-1,3 -oxazolan-2-one
03/25/2004US20040058965 Alkanoic acid derivatives process for their production and use thereof
03/25/2004US20040058934 Heterocyclic compounds
03/25/2004US20040058917 Wound healing agents; antiscarring agents
03/25/2004US20040058913 Cyclic diamine compound with condensed-ring groups
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004CA2498532A1 Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
03/25/2004CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease
03/25/2004CA2483771A1 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers
03/24/2004EP1400515A1 Cyclic diamine compound having five-membered cyclic group
03/24/2004EP1400510A1 Cyclic diamine compounds having fused-ring groups
03/24/2004EP1399421A1 Substituted imidates as pesticidal agents
03/24/2004EP1399146A1 Novel compounds and compositions as cathepsin inhibitors
03/24/2004EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/24/2004EP0904079B1 Antidiabetic agents
03/24/2004CN1483729A Method for preparing 5-phenoxymethoy 1-2-ephedroxane
03/24/2004CN1483728A Process for preparation of oxo-oxazoline or alloamino acid derivatives
03/24/2004CN1142904C One-step process synthetizing 2-oxazolidone derivative interediate and preparation process thereof
03/23/2004US6710205 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/23/2004US6710063 Activators of PPAR delta
03/23/2004US6710045 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (IV)
03/18/2004WO2004022649A1 Resin composition
03/18/2004WO2004022583A1 Versatile linker compound and ligand, and method for preparation thereof
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2004022060A2 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
03/18/2004WO2003099192A3 Bis-aromatic alkanols
03/18/2004WO2003020698A3 Protein tyrosine kinase inhibitors
03/18/2004WO2003018535A3 Novel aminobenzoephenones
03/18/2004US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders
03/18/2004US20040053935 Anticancer agents
03/18/2004US20040053934 Anticancer agents
03/18/2004US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
03/18/2004CA2765185A1 Resin composition
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004CA2497827A1 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
03/17/2004EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy
03/17/2004EP1397367A2 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
03/17/2004EP1397353A1 2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds useful as insecticides and acaricides
03/17/2004EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
03/17/2004CN1483024A Vla-4 inhibitors